0001193125-09-227899 Sample Contracts

Territory License Agreement between Molecular Insight Pharmaceuticals, Inc and BIOMEDICA Life Sciences, S.A.
Territory License Agreement • November 9th, 2009 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations

This territory license agreement (“Agreement”), dated this 1st day of September, 2009 (the “Effective Date”) is entered into by and between Molecular Insight Pharmaceuticals, Inc. (referred to herein as “MIP”), a corporation organized and existing under the laws of The Commonwealth of Massachusetts and having its principal office at 160 Second Street, Cambridge, MA 02142 USA, and BIOMEDICA Life Sciences S.A., a corporation organized and existing under the laws of Greece, with offices at 4 Papanikoli Str., 15232 Halandri, Athens, Greece (referred to herein as “BIOMEDICA”), with Greek Tax ID of 094413470, from the tax office of FAEE Athens; each a “Party” and collectively the “Parties” hereto.

AutoNDA by SimpleDocs
SUPPLY AGREEMENT BETWEEN BIOMEDICA Life Sciences, S.A. AND MOLECULAR INSIGHT PHARMACEUTICALS, INC. dated as of October 19, 2009
Supply Agreement • November 9th, 2009 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations

This supply agreement (“Agreement”), dated this 19th day of October, 2009 (the “Effective Date”) is entered into by and between Molecular Insight Pharmaceuticals, Inc. (referred to herein as “MIP”), a corporation organized and existing under the laws of The Commonwealth of Massachusetts and having its principal office at 160 Second Street, Cambridge, MA 02142 USA, and BIOMEDICA Life Sciences S.A., a corporation organized and existing under the laws of Greece, with offices at 4 Papanikoli Str., 15232 Halandri, Athens, Greece (referred to herein as “BIOMEDICA”), with Greek Tax ID of EL 094413470, from the tax office of FAEE Athens; each a “Party” and collectively the “Parties” hereto.

Azedra Commercial Facility and Supply Agreement THIS AGREEMENT made in duplicate as of this 6th day of August, 2009
Commercial Facility and Supply Agreement • November 9th, 2009 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario

NOW THEREFORE in consideration of the mutual covenants and agreements herein contained, and subject to the terms and conditions hereinafter set out, the parties hereto agree as follows:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!